Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer

Coleman, R. orcid.org/0000-0002-4275-1043, Woodward, E., Brown, J. et al. (11 more authors) (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment, 127 (2). pp. 429-438. ISSN 0167-6806

Abstract

Metadata

Authors/Creators:
  • Coleman, R. ORCID logo https://orcid.org/0000-0002-4275-1043
  • Woodward, E.
  • Brown, J.
  • Cameron, D.
  • Bell, R.
  • Dodwell, D.
  • Keane, M.
  • Gil, M.
  • Davies, C.
  • Burkinshaw, R.
  • Houston, S.J.
  • Grieve, R.J.
  • Barrett-Lee, P.J.
  • Thorpe, H.
Copyright, Publisher and Additional Information: © 2011 Springer. This is an author-produced version of a paper subsequently published in Breast Cancer Research and Treatment. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Breast cancer; Zoledronic acid; Adjuvant therapy; Safety; Osteonecrosis of the jaw
Dates:
  • Accepted: 25 February 2011
  • Published (online): 11 March 2011
  • Published: 1 June 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 27 Nov 2019 10:14
Last Modified: 27 Nov 2019 11:21
Status: Published
Publisher: Springer
Refereed: Yes
Identification Number: https://doi.org/10.1007/s10549-011-1429-y

Share / Export

Statistics